J Vis Exp, 2024 · DOI: 10.3791/65113 · Published: April 2, 2024
This study introduces a method for disrupting the blood-spinal cord barrier (BSCB) in rats using low-intensity focused ultrasound (LIFU). The technique involves using ultrasonic pulsations at lower intensities than ultrasound and is being tested as a reversible and precise neuromodulatory technology. The method involves administering microbubbles (MBs) intravenously, followed by LIFU sonication to create transient gaps in the capillaries of the spinal cord, allowing substances like drugs to penetrate into the spinal parenchyma. The confirmation of BSCB disruption is visually evaluated by observing the extravasation of Evans blue dye (EBD) into the spinal cord, identifiable by its rich blue color.
BSCB disruption can improve the delivery of therapeutics to the spinal cord, potentially enhancing the treatment of spinal cord injuries and other related conditions.
LIFU-mediated BSCB disruption can be used to modulate immune responses in the spinal cord, offering new avenues for treating autoimmune and inflammatory disorders.
This technique can facilitate neuromodulation in specific regions of the spinal cord, providing a non-invasive method for managing chronic pain and other neurological conditions.